Globe pulsed field ablation for atrial fibrillation
Part of Heart & circulation clinical trials.
This study gathers real-world data on people having a procedure called pulsed field ablation for atrial fibrillation (an irregular heartbeat). It helps doctors learn how well the Globe system works in everyday practice.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are scheduled to have a heart procedure called catheter ablation for atrial fibrillation using the Globe system.
- Your doctor has confirmed you are able to have this type of ablation.
- You are not currently enrolled in any other investigational study of a device, drug, or biologic.
- You are expected to live at least one more year.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new pulsed-field device used during an atrial fibrillation (AF) catheter ablation, aiming to improve safety and effectiveness. It’s for people who have AF and are planning an AF ablation procedure.
This trial tests a new method called pulsed field ablation to treat atrial fibrillation (AF), a type of irregular heartbeat. It aims to safely stop AF episodes by targeting specific areas in the heart, and may help people with paroxysmal (coming and going) or persistent AF who haven't had this procedure before.
This study tests a new type of energy called pulsed field ablation to treat atrial fibrillation, an irregular heartbeat. It aims to see if it is safe and effective for people whose symptoms have not improved with medication.
This trial tests an investigational device that uses pulsed electric fields to precisely target and disable the tiny areas in the heart that cause irregular heartbeats. It's for people with intermittent (paroxysmal) atrial fibrillation who haven't been helped by medications.
This trial tests a new device that uses pulsed electric fields to treat atrial fibrillation (AF), a type of irregular heartbeat. It aims to see if this approach is safe and effective for people with AF that comes and goes or lasts for a short time.
This study tests a new way to do a heart procedure (catheter ablation) for people with ongoing atrial fibrillation (an irregular heartbeat). It uses pulsed-field energy to create a block in the heart that stops abnormal electrical signals. The goal is to improve the procedure's success and reduce risks.
Hear when a new Atrial fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.